Albert Bourla said that the drug is under development, but the company will present it soon.
The US company Pfizer is developing a new version of its coronavirus vaccine that can be stored for up to six months at higher temperatures. Pfizer CEO Albert Bourla announced this on Wednesday to the Axios news portal.
“We’re working on a new version of the [Pfizer] vaccine right now,” he said. “And this vaccine can be stored for up to six months in a regular freezer.”
Bourla added that the company would present the development soon.
The vaccine, developed by Pfizer and the German company BioNTech, can be stored at a temperature of minus 60 to minus 80 degrees Celsius for six months.
In February, Pfizer and BioNTech filed updated data with the Food and Drug Administration, according to which the vaccine can be stored at a temperature of -25 to -15 degrees Celsius for two weeks. The regulator is still considering the information provided. Ampoules of the vaccine developed by Pfizer and BioNTech, after defrosting, can be stored at a temperature of 2 to 8 degrees for no more than five days. The drug is delivered in specially designed thermal containers that can be used as temporary storage for up to 30 days in total, provided they are filled with dry ice every five days.